NSGl 554/l NSG554l Examl 4l –l (NEWl
2026/l 2027l Update)l Nursel Practitionersl
inl Primaryl Carel Il Review|l Questionsl &l
Answersl |l Gradel A|l 100%l Correctl
(Verifiedl Solutions)-l Wilkes
QUESTION
Pelvicl inflammatoryl disease
Answer:
-polymicrobiall infectionl ofl thel upperl genitall tractl associatedl withl STIl neosserial
gonorrhea,l chlaymdial andl endogenousl organismsl including:l anaerobes,l haemophilusl
influenzae,l entericl graml negativel rods,l streptococcil
-mostl commonl inl youngl nulliparous,l sexuallyl activel withl multiplel partnersl
-leadingl causesl ofl ectopicl pregnancyl andl infertilityl
-usel ofl barrierl methodsl mayl providel significantl protection
QUESTION
Pelvicl inflammatoryl disease:l S&S
Answer:
-lowerl abdominall pain,l chills,l fever,l menstruall disturbances,l purulentl cervicall discharge,l
-cervicall andl adnexall tendernessl
-RUQl painl (Fitz-Hughl andl Curtisl syndrome)l mayl indicatel anl associatedl perihepatitis
-dxl isl complicatedl byl subtlel orl mildl symptomsl (postl coitall bleeding,l urinaryl frequency,l
lowl backl pain)
,QUESTION
Pelvicl inflammatoryl disease:l minimuml diagnosticl criteria
Answer:
-cervicall motion,l uterinel orl adnexall tenderness
QUESTION
Pelvicl inflammatoryl disease:l additionall criteria
Answer:
-nol singlel historical,l physical,l laboratoryl findingl isl definitivel forl PIDl
-Criterial forl specificityl ofl dx:l
1.l orall templ >38.3C
2.l abnormall cervical/vaginall dischargel withl whitel cellsl onl salinel microscopyl (>1l
leukocytel perl epitheliall cell)
3.l elevatedl erythrocytel sedimentationl rate
4.l elevatedl C-reactivel protein
5.l laboratoryl documentationl ofl cervicall infectionl w/n.l gonorrheal orl chlamydial
culturel shouldl bel performedl routinelyl butl txl shouldl notl bel delayedl whilel awaitingl
results
QUESTION
Pelvicl inflammatoryl disease:l treatmentl mild/moderate
Answer:
Earlyl txl ofl abxl
, Mildl tol moderate:l outpatientl txl withl singlel dosel cefoxtinl 2gl IMl withl probenecidl 1gl
POl +l doxyl 100mgl POl BIDl forl 14l daysl orl ceftriazonel 250l mgl IMl +l doxyl 100mgl POl
BIDl forl 14l daysl
metronidazolel 500mgl POl BIDl forl 14l daysl canl bel addedl tol eitherl andl treatl bacteriall
vaginosisl frequentl associatedl withl PID
QUESTION
Combinedl Orall Contraceptives:l efficacyl andl methodsl ofl use
Answer:
-suppressionl ofl ovulation
-canl startl onl thel 1stl dayl ofl menstruall cycle,l thel 1stl Sundayl afterl thel onsetl ofl thel
cyclel orl onl anyl dayl ofl thel cyclel (backupl methodl shouldl bel usedl ifl startedl onl anyl
day)l
-ifl activel pilll isl missedl atl anyl time,l andl nol intercoursel occurredl inl 5l daysl prior,l 2l
pillsl shouldl bel takenl immediatelyl &l backupl methodl forl 7l daysl after
-ifl intercoursel inl 5l days,l emergencyl contraceptionl shouldl bel usedl immediately,l pillsl
shouldl bel restartedl thel followingl dayl &l backupl methodl forl 5l days
QUESTION
Combinedl Orall Contraceptives:l Benefitsl ofl contraception
Answer:
-lighterl menses
-improvementl ofl dysmenorrheal
-decreasedl riskl ofl endometriall cancer
-improvementl ofl acne
-lowerl riskl ofl myomasl ifl takenl longerl thanl 4l years
-bonel mass
2026/l 2027l Update)l Nursel Practitionersl
inl Primaryl Carel Il Review|l Questionsl &l
Answersl |l Gradel A|l 100%l Correctl
(Verifiedl Solutions)-l Wilkes
QUESTION
Pelvicl inflammatoryl disease
Answer:
-polymicrobiall infectionl ofl thel upperl genitall tractl associatedl withl STIl neosserial
gonorrhea,l chlaymdial andl endogenousl organismsl including:l anaerobes,l haemophilusl
influenzae,l entericl graml negativel rods,l streptococcil
-mostl commonl inl youngl nulliparous,l sexuallyl activel withl multiplel partnersl
-leadingl causesl ofl ectopicl pregnancyl andl infertilityl
-usel ofl barrierl methodsl mayl providel significantl protection
QUESTION
Pelvicl inflammatoryl disease:l S&S
Answer:
-lowerl abdominall pain,l chills,l fever,l menstruall disturbances,l purulentl cervicall discharge,l
-cervicall andl adnexall tendernessl
-RUQl painl (Fitz-Hughl andl Curtisl syndrome)l mayl indicatel anl associatedl perihepatitis
-dxl isl complicatedl byl subtlel orl mildl symptomsl (postl coitall bleeding,l urinaryl frequency,l
lowl backl pain)
,QUESTION
Pelvicl inflammatoryl disease:l minimuml diagnosticl criteria
Answer:
-cervicall motion,l uterinel orl adnexall tenderness
QUESTION
Pelvicl inflammatoryl disease:l additionall criteria
Answer:
-nol singlel historical,l physical,l laboratoryl findingl isl definitivel forl PIDl
-Criterial forl specificityl ofl dx:l
1.l orall templ >38.3C
2.l abnormall cervical/vaginall dischargel withl whitel cellsl onl salinel microscopyl (>1l
leukocytel perl epitheliall cell)
3.l elevatedl erythrocytel sedimentationl rate
4.l elevatedl C-reactivel protein
5.l laboratoryl documentationl ofl cervicall infectionl w/n.l gonorrheal orl chlamydial
culturel shouldl bel performedl routinelyl butl txl shouldl notl bel delayedl whilel awaitingl
results
QUESTION
Pelvicl inflammatoryl disease:l treatmentl mild/moderate
Answer:
Earlyl txl ofl abxl
, Mildl tol moderate:l outpatientl txl withl singlel dosel cefoxtinl 2gl IMl withl probenecidl 1gl
POl +l doxyl 100mgl POl BIDl forl 14l daysl orl ceftriazonel 250l mgl IMl +l doxyl 100mgl POl
BIDl forl 14l daysl
metronidazolel 500mgl POl BIDl forl 14l daysl canl bel addedl tol eitherl andl treatl bacteriall
vaginosisl frequentl associatedl withl PID
QUESTION
Combinedl Orall Contraceptives:l efficacyl andl methodsl ofl use
Answer:
-suppressionl ofl ovulation
-canl startl onl thel 1stl dayl ofl menstruall cycle,l thel 1stl Sundayl afterl thel onsetl ofl thel
cyclel orl onl anyl dayl ofl thel cyclel (backupl methodl shouldl bel usedl ifl startedl onl anyl
day)l
-ifl activel pilll isl missedl atl anyl time,l andl nol intercoursel occurredl inl 5l daysl prior,l 2l
pillsl shouldl bel takenl immediatelyl &l backupl methodl forl 7l daysl after
-ifl intercoursel inl 5l days,l emergencyl contraceptionl shouldl bel usedl immediately,l pillsl
shouldl bel restartedl thel followingl dayl &l backupl methodl forl 5l days
QUESTION
Combinedl Orall Contraceptives:l Benefitsl ofl contraception
Answer:
-lighterl menses
-improvementl ofl dysmenorrheal
-decreasedl riskl ofl endometriall cancer
-improvementl ofl acne
-lowerl riskl ofl myomasl ifl takenl longerl thanl 4l years
-bonel mass
